| Identification | Back Directory | [Name]
CK 3197 | [CAS]
132523-92-3 | [Synonyms]
CK 3197
1-Benzoyl-4-ethyl-5-[4-(2-methyl-2-imidazolin-1-yl)benzoyl]-1H-imidazol-2(3H)-one | [Molecular Formula]
C23H22N4O3 | [MOL File]
132523-92-3.mol | [Molecular Weight]
402.45 |
| Hazard Information | Back Directory | [Description]
CK 3197 is a selective positive inotropic agent for the treatment of congestive heart failure. It has hemodynamic and myocardial energetic effects. | [Uses]
CK-3197 is a weak inhibitor of Peak lll cyclic 3'5'-adenosine monophosphate phosphodiesterase
(CAMP PDEl). CK-3197 has hemodynamic and myocardial energetic effects in vivo. CK-3197 is an imidazolone derivative used as a selective positive inotropic agent for congestive heart failure[1]. | [References]
[1] Greenberg S, et al. Hemodynamic and myocardial energetic effects of CK-3197, a selective positive inotropic agent. J Cardiovasc Pharmacol. 1991 Jan;17(1):145-53. DOI:10.1097/00005344-199101000-00021 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|